1-3 of 3
Zandra Klippel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Thierry Facon, Jae Hoon Lee, Philippe Moreau, Ruben Niesvizky, Meletios Dimopoulos, Roman Hajek, Ludek Pour, Artur Jurczyszyn, Lugui Qiu, Zandra Klippel, Anita Zahlten-Kumeli, Muhtarjan Osman, Bruno Paiva, Jesus San-Miguel
Journal: Blood
Blood (2019) 133 (18): 1953–1963.
https://doi.org/10.1182/blood-2018-09-874396
Published: 2019
Includes: Supplemental data
Journal Articles

Risk of Febrile Neutropenia (FN) in Select Myelosuppressive Chemotherapy Regimens

Leila Family, PhD, Su-Jau Yang, Zandra Klippel, MD, Yanli Li, MD PhD, John H Page, MD ScD, Roberto Rodriguez, MD, Chun Chao, PhD
Journal: Blood
Blood (2015) 126 (23): 3257.
https://doi.org/10.1182/blood.V126.23.3257.3257
Published: 2015
Journal Articles

Oprozomib, Pomalidomide, and Dexamethasone (OPomd) in Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Initial Results of a Phase 1b Study (NCT01999335)

Jatin Shah, Ruben Niesvizky, MD, Edward Stadtmauer, Robert M. Rifkin, James Berenson, MD, Jesus G. Berdeja, MD, Jeff P. Sharman, MD, Roger Lyons, Zandra Klippel, MD, Hansen Wong, Yu-Lin Chang, Saad Usmani
Journal: Blood
Blood (2015) 126 (23): 378.
https://doi.org/10.1182/blood.V126.23.378.378
Published: 2015